Rational discovery of dual FLT3/HDAC inhibitors as a potential AML therapy.
Wang Z, Wu D, Zhao X, Liu C, Jia S, He Q, Huang F, Cheng Z, Lu T, Chen Y, Chen Y, Yang P, Lu S.
Wang Z, et al. Among authors: jia s.
Eur J Med Chem. 2023 Nov 15;260:115759. doi: 10.1016/j.ejmech.2023.115759. Epub 2023 Aug 28.
Eur J Med Chem. 2023.
PMID: 37659198